Astrazeneca plc - ADR

Big Pharma and The Need for Speed

Could Investors Overdose on Pharmaceuticals?

Innate Pharma Gets $50 Million From AstraZeneca as Monalizumab Phase 3 Lung Cancer Trial Begins

Combination of AstraZeneca’s Vaccine and mRNA Vaccines Found To Be 88% Effective Against COVID-19

Emergent BioSolutions To Resume Production of J&J’s COVID-19 Vaccines